免疫代谢:免疫疗法耐药性的新维度
Chaoyue Xiao1, Wei Xiong2, Yiting Xu3
1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.
Frontiers of medicine
|September 19, 2023
概括
免疫检查点抑制剂 (ICI) 是有前途的,但由于细胞代谢功能障碍,耐药性很常见. 针对免疫代谢提供了新的策略来提高ICI治疗对抗癌症的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢研究研究 代谢研究
背景情况:
- 免疫检查点抑制剂 (ICI) 已经改变了癌症治疗,但面临的挑战是患者的不反应和耐药性.
- 细胞代谢功能障碍是导致ICI耐药性的关键因素.
- 代谢重编程现在在瘤细胞和免疫细胞中得到了认可,这导致了新兴的免疫代谢领域.
研究的目的:
- 在免疫治疗耐药性的背景下,探索新陈代谢重编程在各种瘤透免疫细胞中的作用.
- 从免疫代谢的角度来看,从免疫代谢的角度来看,确定潜在的ICI耐药性的机制.
- 提出代谢干预作为克服ICI耐药性的战略.
主要方法:
- 关于癌症代谢和免疫治疗的当前文献的审查和综合.
- 分析各种瘤透免疫细胞中的代谢重编程.
- 探索代谢干预与ICI的潜在协同组合.
主要成果:
- 免疫细胞中的代谢功能障碍显著影响抗瘤免疫力和ICI疗效.
- 了解免疫代谢提供了对ICI耐药性机制的新见解.
- 针对瘤透免疫细胞中的代谢脆弱性,为增强免疫疗法提供了一个有希望的途径.
结论:
- 免疫细胞的代谢重编程是ICI耐药性的关键因素,但经常被忽视.
- 开发有针对性的代谢干预措施有可能克服耐药性并改善抗瘤反应.
- 对免疫代谢的进一步研究对于优化癌症免疫治疗策略至关重要.
相关概念视频
01:27Tumor Immunotherapy
554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
01:27Cytotoxic T Cells-mediated Immune Response
959
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
959
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K